The leading source for credible citizen reporting

Help | Login | Join Allvoices

Mainstream News

This event is older than two months and is no longer active. Some links older than two months could be broken.

Click here to post a new related report

Melanoma patients live longer on Roche's Avastin

Source: Reuters

Berlin : Germany | 2 months ago

0 0

Berlin on Wednesday, is likely to boost interest in Avastin among melanoma specialists, who may use it on a so-called "off label" basis before formal approval. The drug is already a blockbuster and a key driver for Roche, with global sales of 5.2 billion Swiss francs ($5.02 billion) in 2008 as a treatment...

Reach
Credibility

Related Allvoices Contributions

Dogs help advance cancer research in humans

By: dustgeer

Study on cancerous dogs could provide significant data for human cancer research, potentially leading to better treatments and screening for tumors, said the U.S. National Cancer Institute as quoted by media reports Wednesday. Approximately one million dogs develop cancer in the United States each year, the institute noted, the treatments to ...

about 1 month ago
la grippe A

By: fasylla45

Terminology Originally called swine flu by the World Health [7], this flu has also been named by various international institutions, avian North American [8] flu [9] or new influenza [10] before the WHO does not recommend the name of influenza A (H1N1) April 30, 2009 [11], [12]. The flu of 2009 is indeed the H1N1 subtype of influenza A, ...

28 days ago
What are the swine flu vaccine ingredients?

By: AnneHart

How do you quickly find out what ingredients are in the H1N1 flu virus vaccine, either the shot or the intranasal type? If you can reach your doctor by phone or email, ask your physician which manufacturer is being used. Sometimes the nurse giving the shot can take five minutes to read the name of the manufacturer to you over the ...

7 days ago

News Stories

Oxford Bio's failed cancer vaccine may help some

News Source: Reuters | 2 months ago

A therapeutic cancer vaccine from Oxford BioMedica that failed in a clinical study may still help a subset of patients, researchers said on Tuesday. Shares in the company plunged as much as 18 percent in early trade as investors reacted to the...
Melanoma patients live longer on Roche's Avastin

News Source: Reuters | 2 months ago

Berlin on Wednesday, is likely to boost interest in Avastin among melanoma specialists, who may use it on a so-called "off label" basis before formal approval. The drug is already a blockbuster and a key driver for Roche, with global sales of 5.2...